|
(Health-NewsWire.Net, October 04, 2021 )
Market Overview
Blood plasma is the liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes, obtained through a process known as fractionation.
View full report: https://bit.ly/3a4BIQ0
Market Dynamics
The increasing prevalence of hemophilia is expected to drive the market growth
Hemophilia is an inherited bleeding disorder in which the blood doesn't clot properly due to a lack or decrease in a clotting factor protein. The most common types of hemophilia are hemophilia A, which occurs due to a lack of clotting factor VIII and hemophilia B, which is due to a lack of clotting factor IX.
Either type can lead to uncontrollable bleeding into muscles, organs, and joints, as well as prolonged bleeding following injuries or surgery. The condition primarily affects males. Moreover, researchers from the Centers for Disease Control and Prevention and the U.S. HTC Network conducted a study using 2012–2018 on all male patients who attended federally supported U.S. HTCs.
The study estimated the number of males with hemophilia currently living in the United States and estimated the birth rate of new cases in the United States each year. The current number of males with hemophilia living in the United States is estimated to be between 30,000 and 33,000, and the estimated prevalence of hemophilia in the United States is 12 cases per 100,000 U.S. males for hemophilia A and 3.7 cases per 100,000 U.S. males for hemophilia B.
Additionally, hemophilia prevalence differs widely across the United States. It is highest in Midwestern and Northeastern states, as the estimated incidence of hemophilia among U.S. births is one birth per 5,617 male births for hemophilia A and one birth per 19,283 male births for hemophilia B. Thus, from the above statements, the market is expected to drive in the forecast period.
Segment Analysis
By Type
• Albumin
• Factor VIII
• Factor IX
By Application
• Hemophilia
• Hypogammaglobulinemia
• Immunodeficiency Diseases
By End user
• Hospitals
• Clinics
Download free sample: https://bit.ly/3oJJwzh
Geographical Analysis
North America region holds the largest market share in the global blood plasma derivatives market
North America accounted for the largest market share in 2020 and is expected to dominate the market over the forecast period, owing to growing awareness regarding the use and availability of plasma derivatives and the high adoption of advanced technology and large players. For instance, according to the World Health Organization, awareness of the value of plasma for the manufacture of Plasma-derived medicinal products (PDMPs) and a responsibility to avoid the competent health authority establishes wastage of plasma that could be fractionated as part of the national blood policy.
Moreover, supplying plasma to a fractionator can provide an economic return on the cost of investment in quality. Income from supplying plasma can enable blood organizations to achieve their mission of providing an adequate supply of safe blood products for transfusion through the funding of critical operations, enhancing blood center sustainability. The awareness of policy-makers is enhanced on the role of human plasma both for clinical use and particularly as a raw material for the fractionation and manufacture of PDMPs.
Competitive Landscape
The blood plasma derivatives market is highly competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Grifols, S.A., SK Plasma Co., Ltd., Fusion Health Care Pvt. Ltd., Biotest AG, Green Cross Corporation, Baxter International Inc., LFB S.A., Octapharma AG, CSL Limited and Shire Plc.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the blood plasma derivatives market globally.
Related Topic's
Blood Platelets Market, Blood Flow Measurement Devices Market, Blood Gas Monitoring Market, Blood Pressure Monitoring Devices Market, Plasma Feed Market
DataM Intelligence
Sai Kiran
+1 877 441 4866
pr@datamintelligence.com
Source: EmailWire.Com 
|
